covid 19 testing
Market Herald logo


Be the first with the news that moves the market
  • Datametrex AI’s common shares began trading today on the OTCQB today under the current stock symbol DTMXF
  • Listing on the OTCQB provides greater visibility and makes the company’s shares available to a much larger group of U.S. investors
  • Datametrex AI Limited is a technology-focused company
  • Datametrex AI Limited (DM) is down 2.08 per cent, trading at C$0.235 per share at 11:30 am ET

Datametrex AI’s common shares are now trading on the OTCQB under the symbol DTMXF.

The company’s shares will remain listed on the TSX Venture Exchange under the ticker symbol DM.

Existing U.S. shareholders of Datametrex AI Limited shares, previously quoted on the OTC® Pink Open Market, will now be quoted on the OTCQB. No further action is needed.

Marshall Gunter, CEO of Datametrex AI Limited,

“With the company’s shares now quoted on the OTCQB, it will enhance our visibility and make the company’s shares available to a much larger group of U.S. investors. The quotation on the OTCQB is anticipated to enhance liquidity by providing current and prospective investors with an easily accessible and transparent trading platform where they go and obtain Real-Time quotes and market information.”

The OTCQB® Venture Market is the premier marketplace for entrepreneurial and development stage US and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.

 When shares are able to trade electronically, existing investors benefit from greater liquidity and execution speeds, while opening the door to new investors that may have been previously restricted from the company’s shares.

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.

Datametrex AI Limited (DM) is down 2.08 per cent, trading at C$0.235 per share at 11:30 am ET.

More From The Market Herald
Theratechnologies - Chief Medical Officer and Senior Vice President Dr. Christian Marsolais

" Theratechnologies (TSX:TH) confirms effectiveness of PDCs against vasculogenic mimicry

Theratechnologies (TH) reports its investigational peptide-drug conjugates (PDCs) are effective in inhibiting vasculogenic mimicry (VM) in ovarian and breast cancer models.

" Algernon Pharmaceuticals (CSE:AGN) receives $2M payment and applies for Nasdaq listing

Algernon Pharmaceuticals (AGN) has recently received a $2M cash payment from a refundable tax credit program for its clinical research work in Australia.

" MediPharm Labs (TSX:LABS) appoints new CEO

 MediPharm Labs (LABS) is pleased to announce that Bryan Howcroft will join MediPharm Labs as Chief Executive Officer and Director, effective November 15,

" Levitee Labs (CSE:LVT) enters into credit facility for up to $12 Million

Levitee Labs Inc. (LVT) has entered into a financing agreement for up to $12 million to fund further business expansion.